Thermo Fisher Scientific Launches New Portfolio of Chromatography and Mass Spectrometry Consumables
21 February 2022 | Monday | News
New Portfolio of Chromatography and Mass Spectrometry Consumables
Assures Quality and Performance
Image Source : Public Domain
Thermo Scientific SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
A new collection of caps, vials, inserts, kits, well plates and mats improves analytical performance and sample security for chromatography and mass spectrometry users in routine and research laboratories, across a diverse range of sectors such as pharma, biopharma, clinical, food, environmental and academia.
The Thermo Scientific SureSTART portfolio is compatible with all add-on and chromatography autosamplers, allowing analysts to use the new portfolio regardless of the instrument vendor. The new collection provides sample security and low compound adsorption, even for challenging, low-level analytes. This provides laboratories with the needed confidence in their results every time, and reduces the time needed for reviewing background peaks or identifying analytes that have shifted retention times. The SureSTART line draws from existing products that have been successful in the market for more than 40 years and improves the product experience—providing precise and consistent measurements between different vials and different lots.
“As a trusted provider of vials, closures and well plates, we continue to innovate to offer laboratories the improved flexibility and assurance needed to meet analytical requirements,” said Detlev Lennartz, product manager, sample handling, chromatography and mass spectrometry, Thermo Fisher. “SureSTART consumables are built from high-quality materials that meet both the performance and price requirements of our customers, providing the confidence they need to analyze challenging analytes. Additionally, the new collection is fully compatible with GC, GC-MS, LC and LC-MS analytical instruments and includes three performance levels to help laboratories choose the right product for their experimental needs.”
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
